Topical delgocitinib appears more effective than oral alitretinoin and is comparable to dupilumab for treating types of hand eczema, according to two separate studies.

A significant inverse association was observed among topical corticosteroid phobia and adherence to treatment among adults with chronic hand eczema.

I have been dealing with eczema for as long as I can remember. In honor of Eczema Awareness Month, here are my favorite ...

The European Commission has approved the topical pan–Janus kinase inhibitors inhibitor delgocitinib for adults with moderate ...

Three eczema warriors share how support from loved ones and the community has helped them navigate the challenges of the skin ...

Alcohol use as a risk factor in infections and healing: a clinician's perspective. Alcohol Res. 2015;37(2):177-84 Loh EW, Yew YW. Hand hygiene and hand eczema: A systematic review and meta-analysis.

The FDA has accepted for filing the NDA for delgocitinib cream as a treatment for moderate to severe chronic hand eczema in adults.

This form of eczema is irritation or an allergic reaction to something that comes into contact with your skin, especially your hands or face. Symptoms may include: An intense itch followed by a ...

Danish dermatology specialist LEO Pharma could be just weeks away from EU approval for delgocitinib, a treatment for chronic hand eczema (CHE) considered to be its top pipeline prospect.

LEO Pharma has presented late-breaking data on the DELTA FORCE trial for Anzupgo (delgocitinib) cream as a potential ...

The European Commission (EC) has granted marketing authorisation to LEO Pharma’s Anzupgo (delgocitinib) cream for treating ...